Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Onxeo and Institut Curie to study benefits of combining radiotherapy, DNA repair inhibitors and immu

pharmaceutical-technologyFebruary 06, 2017

Tag: DNA , combining radiotherapy

PharmaSources Customer Service